- Cimifugin
-
-
2026-06-30
- CAS:37921-38-3
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1000kgs
- Cimifugin
-
- $44.00
-
2026-06-02
- CAS:37921-38-3
- Purity: 99.82%
- Supply Ability: 10g
- Cimifugin
-
-
2024-04-12
- CAS:37921-38-3
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
|
| | Cimifugin Chemical Properties |
| Melting point | 107～109℃ | | Boiling point | 546.4±50.0 °C(Predicted) | | density | 1.361±0.06 g/cm3(Predicted) | | storage temp. | -20°C | | pka | 14.25±0.29(Predicted) | | form | powder | | color | White-beige | | Major Application | pharmaceutical | | InChI | 1S/C16H18O6/c1-16(2,19)13-5-9-11(22-13)6-12-14(15(9)20-3)10(18)4-8(7-17)21-12/h4,6,13,17,19H,5,7H2,1-3H3/t13-/m0/s1 | | InChIKey | ATDBDSBKYKMRGZ-ZDUSSCGKSA-N | | SMILES | [o]1c2c([c](cc1CO)=O)c(c3c(c2)O[C@@H](C3)C(O)(C)C)OC |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | Cimifugin Usage And Synthesis |
| Components | The main components of Cimicifuga are triterpenoid polyoxygenates, chromogen ketones, phenolic acids, various chromones, odontoamol and odontoamicin. Among them, the identified structures are: isoferulic acid, 3-acetyl caffeic acid, caffeic ester glucoside, cimifugin, cimifugin glucoside, 6-isoxanthine nucleoside, cimidahurine, cimidahurinie, D-glucose, sucrose, etc. | | Chemical Properties | Soluble in methanol, DMSO and other solvents, insoluble in petroleum ether. Sourced from the rhizome of Asclepias (Cimicifnga foetida L.) | | Uses | Cimifugin USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
- Siler Root
- Siler Root Dry Extract
- Siler Root Powder
| | Definition | ChEBI: Cimifugin is an oxacycle and an organic heterotricyclic compound. | | in vivo | Cimifugin (Cimitin; 12.5 or 50 mg/kg/day; intragastrically; 2 days) significantly inhibits TSLP and IL-33 in the initial stage of Mice are sensitized and challenged with FITC to establish type 2 atopic dermatitis (AD) model. Simultaneously, Cimifugin reduces the separated gap among the epithelial cells and increased the expression of TJs[1].
| | target | IFN-γ | IL Receptor | AChE | BChE |
| | Cimifugin Preparation Products And Raw materials |
|